The TTVR procedures were performed in our hybrid‐catheter laboratory under general anaesthesia to allow optimal transesophageal echocardiographic and fluoroscopic guidance. In this study, the PASCAL Ace implant system (Edwards, Irvine, CA, USA) was used for TTVR. The device accesses the right atrium via a transfemoral venous approach and consists of a 22 F guide sheath with steerable guide and implantation catheter. For intraprocedural echocardiographic guidance, biplane transgastric, and deep midoesophageal transoesophageal views were used. Procedural, technical, and device success were analysed according to recommendations from the Mitral Valve Academic Research Consortium.18 Procedural success denotes the absence of major device‐ or procedure‐related serious adverse events; technical success denotes the ability of the device to be deployed as intended and the delivery system successfully retrieved without procedural mortality or need for emergency surgery or intervention; and device success describes effectiveness of the device in reducing the severity of TR to optimal or acceptable levels.
Pascal ace
Manufactured by Edwards Lifesciences
Sourced in United States
The PASCAL Ace is a lab equipment product designed for monitoring and managing hemodynamic parameters. It provides real-time data on various cardiovascular measurements to support healthcare professionals in their clinical decision-making processes.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using pascal ace
1
Transcatheter Tricuspid Valve Repair Procedure
2
Transcatheter Tricuspid Valve Repair
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The procedures were performed using MitraClip, TriClip (Abbott Vascular), PASCAL P10, PASCAL Ace (Edwards Lifesciences) devices, or Cardioband device (Edwards Lifesciences), as previously described [6, 26, 27] . As direct annuloplasty is more complex than TEER, both regarding patient screening including computed tomography as well as longer and more complex procedure, TEER is the first treatment choice in daily clinical practice. In general, every patient which showed a tricuspid valve anatomy with difficulty in leaflet grasping (e.g., extremely large coaptation gap, short leaflets, or multiple-scallop leaflets) was evaluated for direct annuloplasty. Technical success was defined as successful device implantation without conversion to emergent TV surgery or re-intervention and absence of mortality, as well as successful deployment and correct positioning of the device. Additionally, procedural success was confirmed if the postprocedural TR grade at discharge was moderate or less (≤ II°).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!